Aquestive Therapeutics, Inc. (AQST) insider trading

By person

23 insiders · 73 transactions

4.1×

Daniel Barber holds only 4.1 times base salary in stock. $2.76M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.22, the price Common Stock was last bought or sold at on the open market here, on 15 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Douglas K Bratton

10% owner

$2.48M (1)

—

+$2.48M

2,161,004

1.72%

$9.13M

−43.0%

Daniel Barber

President and CEO

$104.05K (3)

$1.88M (10) scheduled

−$1.78M

627,317

0.4998%

$2.65M

+683.4%

Alexander Mark Schobel

Chief Innovation/Tech Officer

$79.45K (4)

$1.62M (9)

−$1.54M

984,476

0.7844%

$4.16M

−2.4%

Cassie Jung

Chief Operating Officer

—

$975.90K (4) scheduled

−$975.90K

208,833

0.1664%

$882.11K

+502.6%

Peter E. Boyd

Chief People Officer

$13.53K (5)

$336.91K (4) scheduled

−$323.38K

284,024

0.2263%

$1.20M

+472.0%

A Ernest Toth Jr

Chief Financial Officer

—

$243.09K (1)

−$243.09K

283,460

0.2258%

$1.20M

—

Carl N Kraus

Chief Medical Officer

—

$141.90K (1) scheduled

−$141.90K

282,475

0.2251%

$1.19M

—

Keith J Kendall

CEO and President

$121.18K (9)

$255.31K (1)

−$134.13K

639,149

0.5092%

$2.70M

+4.4%

Julie Krop

Director

—

$125.39K (1) scheduled

−$125.39K

0.0000%

$0.00

—

John T. Maxwell

SVP-Chief Financial Officer

$142.35K (2)

$24.00K (1)

+$118.35K

150,614

0.1200%

$636.19K

+8.7%

Sherry Korczynski

Chief Commercial Officer

—

$111.36K (2)

−$111.36K

235,689

0.1878%

$995.55K

+371.4%

Melina Cioffi

SVP, Regulatory Affairs

—

$105.62K (1)

−$105.62K

273,200

0.2177%

$1.15M

+49.9%

James S Scibetta

Director

$86.98K (3)

—

+$86.98K

31,635

0.0252%

$133.63K

+265.1%

Lori J Braender

Corporate Secretary

$86.15K (4)

$167.35K (1)

−$81.19K

231,042

0.1841%

$975.92K

—

Ken W. Marshall

SVP, Chief Commercial Officer

$14.67K (1)

—

+$14.67K

151,445

0.1207%

$639.70K

—

Theresa Wood

SVP-HR and Org. Development

$9.16K (2)

—

+$9.16K

80,765

0.0643%

$341.15K

+1.9%

Stephen Wargacki

Chief Science Officer

—

343,552

0.2737%

$1.45M

+1,722%

John Cochran

Director

—

161,715

0.1288%

$683.08K

+115.4%

Thomas A. Zalewski

Chief Legal Officer

—

100,000

0.0797%

$422.40K

—

Matthew W. Davis

Chief Development Officer

—

100,000

0.0797%

$422.40K

—

Gregory B Brown

Director

—

75,085

0.0598%

$317.16K

0.0%

Matthew J. Greenhawt

Chief Medical Officer

—

75,000

0.0598%

$316.80K

—

Santo J Costa

Director

—

17,327

0.0138%

$73.19K

0.0%

Aquestive Therapeutics, Inc.

What the insiders did Balanced

By person